Carl G Figdor

15PUBLICATIONS
106CO-AUTHORS
Supramolecular chemistryApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nanofabrication, growth and self assemblyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 09, 2025
Site-directed multivalent conjugation of antibodies to ubiquitinated payloads.

Angela F El Hebieshy, Zacharias Wijfjes, Camille M Le Gall

|Jan 27, 2025
ImmuNet: a segmentation-free machine learning pipeline for immune landscape phenotyping in tumors by multiplex imaging.

Shabaz Sultan, Mark A J Gorris, Evgenia Martynova

|Jun 03, 2024
Generation of nanobodies from transgenic 'LamaMice' lacking an endogenous immunoglobulin repertoire.

Thomas Eden, Alessa Z Schaffrath, Janusz Wesolowski

|Feb 23, 2024
Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trial.

Kalijn F Bol, Gerty Schreibelt, Martine Bloemendal

|Apr 24, 2023
In silico cancer immunotherapy trials uncover the consequences of therapy-specific response patterns for clinical trial design and outcome.

Jeroen H A Creemers, Ankur Ankan, Kit C B Roes

|Oct 17, 2022
Tumor microenvironment shows an immunological abscopal effect in patients with NSCLC treated with pembrolizumab-radiotherapy combination.

Lieke L van der Woude, Mark A J Gorris, Inge M N Wortel

Pageof 3

Frequent Collaborators

11 joint publications

I Jolanda M de Vries

7 joint publications

Johannes Textor

5 joint publications

Mark A J Gorris

4 joint publications

Jeroen H A Creemers